跨模态PET图像合成用于帕金森病诊断:从[18F]FDG到[11C]CFT的跨越
本研究开发深度学习框架,从真实[18F]FDG PET图像合成[11C]CFT PET图像,并利用跨模态相关性区分帕金森病与正常对照。共纳入604名参与者(274例帕金森病,330例正常对照)。合成图像质量高,基于合成图像的放射科医生诊断准确率达91.9%±2.02%,基于后壳核的生物标志物定量分析AUC为0.912(95%CI 0.889-0.936),所提出的帕金森病分类器AUC为0.937(95%CI 0.916-0.957)。
要点
- 深度学习框架可从[18F]FDG PET合成[11C]CFT PET图像,合成图像与真实图像视觉无显著差异。
- 合成[11C]CFT PET图像在不同单侧纹状体亚区具有高峰值信噪比(25.0-28.0)和结构相似性(0.87-0.96)。
- 基于合成图像的放射科医生诊断准确率为91.9%±2.02%,帕金森病分类器AUC为0.937(95%CI 0.916-0.957)。
核心结论
- 该深度学习框架通过桥接[18F]FDG与[11C]CFT,无需[11C]CFT示踪剂即可显著增强帕金森病诊断,从而将先进诊断工具扩展到[11C]CFT PET不可及的临床环境。
研究设计与样本
- 共纳入604名参与者(274例帕金森病,330例正常对照),均接受[11C]CFT和[18F]FDG PET扫描。
- 开发深度学习框架从真实[18F]FDG PET图像合成[11C]CFT PET图像,并利用跨模态相关性区分帕金森病与正常对照。
- 通过定量比较和放射科医生视觉评估评价合成[11C]CFT PET图像质量。
- 采用基于生物标志物的定量分析(使用合成[11C]CFT PET图像的纹状体结合比)和所提出的帕金森病分类器(结合真实[18F]FDG和合成[11C]CFT PET图像)评估帕金森病诊断性能。
主要发现
- 可视化结果显示合成[11C]CFT PET图像与真实图像相似,误差图中未见显著差异。
- 定量评价显示合成[11C]CFT PET图像在不同单侧纹状体亚区具有高峰值信噪比(PSNR:25.0-28.0)和结构相似性(SSIM:0.87-0.96)。
- 放射科医生基于合成[11C]CFT PET图像的诊断准确率为91.9%±2.02%。
- 基于后壳核的生物标志物定量分析AUC为0.912(95%CI,0.889-0.936)。
- 所提出的帕金森病分类器AUC为0.937(95%CI,0.916-0.957)。
关键数值与推荐
- 合成[11C]CFT PET图像质量:PSNR 25.0-28.0,SSIM 0.87-0.96(不同单侧纹状体亚区)。
- 放射科医生基于合成图像的诊断准确率:91.9%±2.02%。
- 基于后壳核的生物标志物定量分析AUC:0.912(95%CI,0.889-0.936)。
- 帕金森病分类器AUC:0.937(95%CI,0.916-0.957)。
临床怎么用
- 原文结论指出该框架无需[11C]CFT示踪剂即可增强帕金森病诊断,可将先进诊断工具扩展到[11C]CFT PET不可及的临床环境。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Dopamine transporter [11C]CFT PET is highly effective for diagnosing Parkinson's Disease (PD), whereas it is not widely available in most hospitals. To develop a deep learning framework to synthesize [11C]CFT PET images from real [18F]FDG PET images and leverage their cross-modal correlation to distinguish PD from normal control (NC). METHODS: We developed a deep learning framework to synthesize [11C]CFT PET images from real [18F]FDG PET images, and leveraged their cross-modal correlation to distinguish PD from NC. A total of 604 participants (274 with PD and 330 with NC) who underwent [11C]CFT and [18F]FDG PET scans were included. The quality of the synthetic [11C]CFT PET images was evaluated through quantitative comparison with the ground-truth images and radiologist visual assessment. The evaluations of PD diagnosis performance were conducted using biomarker-based quantitative analyses (using striatal binding ratios from synthetic [11C]CFT PET images) and the proposed PD classifier (incorporating both real [18F]FDG and synthetic [11C]CFT PET images). RESULTS: Visualization result shows that the synthetic [11C]CFT PET images resemble the real ones with no significant differences visible in the error maps. Quantitative evaluation demonstrated that synthetic [11C]CFT PET images exhibited a high peak signal-to-noise ratio (PSNR: 25.0-28.0) and structural similarity (SSIM: 0.87-0.96) across different unilateral striatal subregions. The radiologists achieved a diagnostic accuracy of 91.9% (± 2.02%) based on synthetic [11C]CFT PET images, while biomarker-based quantitative analysis of the posterior putamen yielded an AUC of 0.912 (95% CI, 0.889-0.936), and the proposed PD Classifier achieved an AUC of 0.937 (95% CI, 0.916-0.957). CONCLUSION: By bridging the gap between [18F]FDG and [11C]CFT, our deep learning framework can significantly enhance PD diagnosis without the need for [11C]CFT tracers, thereby expanding the reach of advanced diagnostic tools to clinical settings where [11C]CFT PET imaging is inaccessible.
引用
- Shen Z, Wang J, Huang H, et al. Cross-modality PET image synthesis for Parkinson's Disease diagnosis: a leap from [18F]FDG to [11C]CFT. Eur J Nucl Med Mol Imaging. 2025. PMID: 39828866. doi:10.1007/s00259-025-07096-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。